{
    "organizations": [],
    "uuid": "2c8a58219fc6ba1476ee0795b0cef94844a16447",
    "author": "",
    "url": "https://www.reuters.com/article/brief-inovio-pharmaceuticals-says-for-qt/brief-inovio-pharmaceuticals-says-for-qtr-ended-march-31-net-loss-per-share-was-0-36-idUSFWN1SG1J5",
    "ord_in_thread": 0,
    "title": "BRIEF-Inovio Pharmaceuticals Says For Qtr Ended March 31, Net Loss Per Share Was $0.36",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9, 2018 / 8:02 PM / Updated 11 minutes ago BRIEF-Inovio Pharmaceuticals Says For Qtr Ended March 31, Net Loss Per Share Was $0.36 Reuters Staff 1 Min Read\nMay 9 (Reuters) - Inovio Pharmaceuticals Inc:\n* INOVIO PHARMACEUTICALS SAYS FOR THREE MONTHS ENDED MARCH 31, 2018, NET LOSS PER SHARE WAS $0.36 - SEC FILING\n* INOVIO PHARMACEUTICALS INC QTRLY TOTAL REVENUES $1.5 MILLION VERSUS $10.4 MILLION Source text: ( bit.ly/2FXrKyl ) ",
    "published": "2018-05-09T22:59:00.000+03:00",
    "crawled": "2018-05-09T23:16:48.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "say",
        "qtr",
        "ended",
        "march",
        "net",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "inovio",
        "pharmaceutical",
        "inc",
        "inovio",
        "pharmaceutical",
        "say",
        "three",
        "month",
        "ended",
        "march",
        "net",
        "loss",
        "per",
        "share",
        "sec",
        "filing",
        "inovio",
        "pharmaceutical",
        "inc",
        "qtrly",
        "total",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text"
    ]
}